drugset / Trial / NCT01682226
Cord Blood With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cell Transplantation for Hematological Malignancies
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to find out whether the addition of blood stem cells from a close family member, when added to umbilical cord blood will make the transplant safer.
Timeline
- Start
- 2012-09-05
- Primary completion
- 2021-01-08
- Completion
- 2021-01-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Haploidentical donor CD34+ cells | Cell therapy | — | — |